https://orcid.org/0000-0003-3975-5550
References
- Kandaswamy E, Zuo L. Recent advances in treatment of coronary artery disease: role of science and technology. Int J Mol Sci. 2018;19(2):424. doi:10.3390/ijms19020424
- Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(3):E4–E17. doi:10.1161/CIR.0000000000001039
- McCarthy CP, Steg GP, Bhatt DL. The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum. Eur Heart J. 2017;38(47):3488–3492. doi:10.1093/eurheartj/ehx531
- Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation. 2009;119(18):2454–2462. doi:10.1161/CIRCULATIONAHA.108.827162
- Siao WZ, Chuang WY, Su CH, Huang SF, Tu WK, Chan KC. A rare case of ticagrelor-induced profound isolated thrombocytopenia. Acta Cardiol Sin. 2017;33(5):556–558. doi:10.6515/acs20161021c
- Dobesh PP, Oestreich JH. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy. 2014;34(10):1077–1090. doi:10.1002/phar.1477
- Steiner JB, Wu Z, Ren J. Ticagrelor: positive, negative and misunderstood properties as a new antiplatelet agent. Clin Exp Pharmacol Physiol. 2013;40:398–403. doi:10.1111/1440-1681.12097
- Kowalczyk M, Banach M, Mikhailidis DP, Hannam S, Rysz J. Ticagrelor-a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? Med Sci Monit. 2009;15(12):MS24–MS30.
- Khan MR, Adhikari G, Khan H, et al. A case report of absolute thrombocytopenia with ticagrelor. Eur Heart J Case Rep. 2020;4(4):1–5. doi:10.1093/ehjcr/ytaa169
- Doğan A, Özdemir B, Bal H, Özdemir E, Kurtoğlu N. Ticagrelor-associated thrombotic thrombocytopenic purpura. Anatol J Cardiol. 2017;17:73–74.
- Yong CH, Manchanda S, Varikara K. Ticagrelor-induced immune thrombocytopenia & response to high dose dexamethasone. Intern Med J. 2018;48:21. doi:10.1111/imj.29_13827
- Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010;116(12):2127–2133. doi:10.1182/blood-2010-03-276691
- Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J. 2007;83(983):575–582. doi:10.1136/pgmj.2007.059188